The JAMM motif of human deubiquitinase Poh1 is essential for cell viability

被引:61
作者
Gallery, Melissa [1 ]
Blank, Jonathan L. [1 ]
Lin, Yinghui [1 ]
Gutierrez, Juan A. [1 ]
Pulido, Jacqueline C. [1 ]
Rappoli, David [1 ]
Badola, Sunita [1 ]
Rolfe, Mark [1 ]
MacBeth, Kyle J. [1 ]
机构
[1] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1158/1535-7163.MCT-06-0542
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Poh1 deubiquitinase activity is required for proteolytic processing of polyubiquitinated substrates by the 26S proteasome, linking deubiquitination to complete substrate degradation. Poh1 RNA interference (RNAi) in HeLa cells resulted in a reduction in cell viability and an increase in polyubiquitinated protein levels, supporting the link between Poh1 and the ubiquitin proteasome pathway. To more specifically test for any requirement of the zinc metalloproteinase motif of Poh1 to support cell viability and proteasome function, we developed a RNAi complementation strategy. Effects on cell viability and proteasome activity were assessed in cells with RNAi of endogenous Poh1 and induced expression of wild-type Poh1 or a mutant form of Poh1, in which two conserved histidines of the proposed catalytic site were replaced with alanines. We show that an intact zinc metalloproteinase motif is essential for cell viability and 26S proteasome function. As a required enzymatic component of the proteasome, Poh1 is an intriguing therapeutic drug target for cancer.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 37 条
[21]   MPN plus , a putative catalytic motif found in a subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for Rpn11 function [J].
Maytal-Kivity, Vered ;
Reis, Noa ;
Hofmann, Kay ;
Glickman, Michael H. .
BMC BIOCHEMISTRY, 2002, 3 :1-12
[22]   Proteasomes and their kin: Proteases in the machine age [J].
Pickart, CM ;
Cohen, RE .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (03) :177-187
[23]  
PULIDO JC, 1994, CURRENT PROTOCOLS HU
[24]   Proteasome inhibition as a novel therapeutic target in human cancer [J].
Rajkumar, SV ;
Richardson, PG ;
Hideshima, T ;
Anderson, KC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) :630-639
[25]  
Richardson PG, 2005, CELL CYCLE, V4, P290
[26]   A mutation in a novel yeast proteasomal gene, RPN11/MPR1, produces a cell cycle arrest, overreplication of nuclear and mitochondrial DNA, and an altered mitochondrial morphology [J].
Rinaldi, T ;
Ricci, C ;
Porro, D ;
Bolotin-Fukuhara, M ;
Frontali, L .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (10) :2917-2931
[27]   Participation of the proteasomal lid subunit Rpn11 in mitochondrial morphology and function is mapped to a distinct C-terminal domain [J].
Rinaldi, T ;
Pick, E ;
Gambadoro, A ;
Zilli, S ;
Maytal-Kivity, V ;
Frontali, L ;
Glickman, MH .
BIOCHEMICAL JOURNAL, 2004, 381 :275-285
[28]   Mitochondrial effects of the pleiotropic proteasomal mutation mpr1/rpn11:: uncoupling from cell cycle defects in extragenic revertants [J].
Rinaldi, T ;
Ricordy, R ;
Bolotin-Fukuhara, M ;
Frontali, L .
GENE, 2002, 286 (01) :43-51
[29]   Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunit [J].
Spataro, V ;
Toda, T ;
Craig, R ;
Seeger, M ;
Dubiel, W ;
Harris, AL ;
Norbury, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30470-30475
[30]  
Spataro V, 2002, ANTICANCER RES, V22, P3905